1	9 Patients who have received live attenuated vaccines within 1 week of start of everolimus and during the study|everolimus[80,90]|||||||1 week[61,67]||C0541315|141704|141704|everolimus
1	9 Patients who have received live attenuated vaccines within 1 week of start of everolimus and during the study|attenuated vaccines[34,53]|||||||||C0042210|11094|11094|attenuated vaccines
